‘This an important clinical trial for infants is because it retains the potential to lung health with a new approach, ‘said Preston W. Campbell, executive vice president of medical affairs for the CF Foundation. click to read
Each child in the study, the treatment for a year is obtained, but it is expected that take five years, to complete the entire study, Davis said.In addition to Davis, the study investigators are Dr. Margaret Rosenfeld, the Children’s Hospital and Regional Medical Center in Seattle, Felix Ratjen of The Hospital for Sick Children in Toronto. Other UNC investigators participating in the trial are Dr. Scott Donaldson and respiratory therapist Robin.
The early detection of ovarian cancer is the most important factor to improving estimates for female diagnosed with the disease, said Nancy Sclater, executive director of the Marsha Rivkin Center ovarian Research. .